Home » Topics » Regulatory » Patents

Patents
RSS

Nimbus Therapeutics patents IRAK-4 inhibitors

Jan. 18, 2017

Merck & Co. discloses novel PI3Kdelta inhibtors

Jan. 18, 2017

Pierre Fabre reports Plk-1 inhibitors

Jan. 17, 2017

GlaxoSmithKline patents EZH2 inhibitors for cancer

Jan. 17, 2017

AnaMar reports 5-HT2B receptor antagonists

Jan. 17, 2017

Team in Portugal describes antimalarial agents

Jan. 17, 2017

Sumitomo Dainippon Pharma report compounds for treatment of cancer

Jan. 17, 2017

Bristol-Myers Squibb patents IRAK-4 inhibitors

Jan. 17, 2017

Nanyang Technological University reports viral entry inhibitors

Jan. 16, 2017

Ono Pharmaceutical patents BRK inhibitors for cancer

Jan. 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...